Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Numinus announces Clinical Advisory Council to advance integrated wellness model

Numinus announces Clinical Advisory Council to advance integrated wellness model

  • Post published:June 24, 2020
  • Post category:Press Release
Read more about the article Numinus Licencing Amendment: We Speak to the Team

Numinus Licencing Amendment: We Speak to the Team

  • Post published:June 12, 2020
  • Post category:News
Read more about the article Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

  • Post published:June 11, 2020
  • Post category:Press Release
Read more about the article Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director

Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director

  • Post published:June 3, 2020
  • Post category:Press Release
Read more about the article Numinus Announces 2020 Operational Plans to Scale

Numinus Announces 2020 Operational Plans to Scale

  • Post published:May 28, 2020
  • Post category:Press Release
Read more about the article Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council

Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council

  • Post published:May 26, 2020
  • Post category:Press Release
Read more about the article Interview with Dr. Evan Wood, CMO at Numinus

Interview with Dr. Evan Wood, CMO at Numinus

  • Post published:May 22, 2020
  • Post category:Interview
Read more about the article Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer

Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer

  • Post published:May 21, 2020
  • Post category:Press Release
Read more about the article Numinus Wellness Inc. commences trading on TSX Venture Exchange as NUMI

Numinus Wellness Inc. commences trading on TSX Venture Exchange as NUMI

  • Post published:May 20, 2020
  • Post category:Press Release
Read more about the article NUMI Begins Appearing on Brokerages, Available for Pre-market Orders on Some

NUMI Begins Appearing on Brokerages, Available for Pre-market Orders on Some

  • Post published:May 20, 2020
  • Post category:News

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More